Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panaccione

Showing results (1-10 of 652) with videos related to

Pageof 66
Sort By:
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|June 29, 2001
Infliximab for the treatment of Crohn's disease: review and indications for clinical use in CanadaR Panaccione,
Crohn'S & Colitis 360|February 13, 2023
The Great Debate With IBD Biosimilars: Con: Biosimilars Should Not Be Routinely Used as a First Line Biologic and Not Switched From Reference BiologicsRemo Panaccione
Journal of the Canadian Association of Gastroenterology|February 24, 2025
What is first-line and what is second-line therapy in adult patients with moderate to severe Crohn's disease?Remo Panaccione
Microbial Biotechnology|January 13, 2023
Derivation of the multiply-branched ergot alkaloid pathway of fungiDaniel G Panaccione
FEMS Microbiology Letters|August 23, 2005
Origins and significance of ergot alkaloid diversity in fungiDaniel G Panaccione
Trends in Microbiology|April 1, 1993
The fungal genus Cochliobolus and toxin-mediated plant diseaseD G Panaccione
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 10, 2008
Anti-adhesion molecule strategies for Crohn diseaseYvette Leung, Remo Panaccione
Current Opinion in Gastroenterology|July 16, 2008
Biologic therapy in Crohn's disease: state of the artJennifer Jones, Remo Panaccione
Therapeutic Advances in Gastroenterology|December 25, 2010
Anti-adhesion molecule therapy for inflammatory bowel diseaseSubrata Ghosh, Remo Panaccione
Gastroenterology Clinics of North America|August 12, 2014
Update on ustekinumab for the treatment of Crohn's diseaseYvette Leung, Remo Panaccione
Pageof 66

Showing results (1-10 of 652) with videos related to

Sort By:
Pageof 66
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|June 29, 2001
Infliximab for the treatment of Crohn's disease: review and indications for clinical use in CanadaR Panaccione,
Crohn'S & Colitis 360|February 13, 2023
The Great Debate With IBD Biosimilars: Con: Biosimilars Should Not Be Routinely Used as a First Line Biologic and Not Switched From Reference BiologicsRemo Panaccione
Journal of the Canadian Association of Gastroenterology|February 24, 2025
What is first-line and what is second-line therapy in adult patients with moderate to severe Crohn's disease?Remo Panaccione
Microbial Biotechnology|January 13, 2023
Derivation of the multiply-branched ergot alkaloid pathway of fungiDaniel G Panaccione
FEMS Microbiology Letters|August 23, 2005
Origins and significance of ergot alkaloid diversity in fungiDaniel G Panaccione
Trends in Microbiology|April 1, 1993
The fungal genus Cochliobolus and toxin-mediated plant diseaseD G Panaccione
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 10, 2008
Anti-adhesion molecule strategies for Crohn diseaseYvette Leung, Remo Panaccione
Current Opinion in Gastroenterology|July 16, 2008
Biologic therapy in Crohn's disease: state of the artJennifer Jones, Remo Panaccione
Therapeutic Advances in Gastroenterology|December 25, 2010
Anti-adhesion molecule therapy for inflammatory bowel diseaseSubrata Ghosh, Remo Panaccione
Gastroenterology Clinics of North America|August 12, 2014
Update on ustekinumab for the treatment of Crohn's diseaseYvette Leung, Remo Panaccione
Pageof 66